Compare DexCom, Inc. (DXCM) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs iShares Global Clean Energy ETF — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while iShares Global Clean Energy ETF trades at $17.28 (market cap $2.27B). The key difference: DexCom, Inc. is far larger — about 14× iShares Global Clean Energy ETF's market cap, and DexCom, Inc. is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and iShares Global Clean Energy ETF for 87 Days on average.
| DXCM | ICLN | |
|---|---|---|
Market Cap | $31.86B | $2.27B |
Volume | 3,607,070 | 6,845,064 |
Sector | Health | — |
52-Week High | $92.34 | $23.75 |
52-Week Low | $54.84 | $15.78 |
Typical Hold Time | 62 Days | 87 Days |
Enterprise Value | $31.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
ICLN trades at $17.12, down 1.1% today, with a bearish technical signal from moving averages and neutral oscillators. The ETF faces volatility in clean energy markets, with recent comparisons highlighting deeper drawdowns versus traditional energy ETFs. News indicates global renewable energy acceleration due to geopolitical tensions, potentially benefiting ICLN's long-term theme.
The outlook remains cautious near-term due to technical weakness and competitive fee pressures, but long-term growth prospects are supported by energy transition trends. Key risks include high volatility, expense ratios, and fossil fuel competition. Analyst sentiment is mixed, weighing near-term headwinds against structural shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
